Acute myeloid leukemia occurring in childhood.
Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation surrounding childhood acute myeloid leukemia is limited due to its relative rarity compared to other cancers. This condition affects fewer children, which results in fewer systematic clinical studies. Additionally, the complexity of the disease and the variability in clinical presentation make comprehensive characterization challenging. Ongoing research is essential to enhance understanding and treatment options.
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
There are currently 29 active clinical trials focused on childhood acute myeloid leukemia, which aim to explore new treatments and improve outcomes. Notable orphan drugs approved for use include Azacitidine and Gemtuzumab ozogamicin, among others. For more details on ongoing trials, you can search on ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=childhood%20acute%20myeloid%20leukemia.
Actionable guidance for navigating care for childhood acute myeloid leukemia
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding childhood acute myeloid leukemia is limited due to its relative rarity compared to other cancers. This condition affects fewer children, which results in fewer systematic clinical studies. Additionally, the complexity of the disease and the variability in clinical presentation make comprehensive characterization challenging. Ongoing research is essential to enhance understanding and treatment options.
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
There are currently 29 active clinical trials focused on childhood acute myeloid leukemia, which aim to explore new treatments and improve outcomes. Notable orphan drugs approved for use include Azacitidine and Gemtuzumab ozogamicin, among others. For more details on ongoing trials, you can search on ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=childhood%20acute%20myeloid%20leukemia.
Actionable guidance for navigating care for childhood acute myeloid leukemia
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation surrounding childhood acute myeloid leukemia is limited due to its relative rarity compared to other cancers. This condition affects fewer children, which results in fewer systematic clinical studies. Additionally, the complexity of the disease and the variability in clinical presentation make comprehensive characterization challenging. Ongoing research is essential to enhance understanding and treatment options.
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
There are currently 29 active clinical trials focused on childhood acute myeloid leukemia, which aim to explore new treatments and improve outcomes. Notable orphan drugs approved for use include Azacitidine and Gemtuzumab ozogamicin, among others. For more details on ongoing trials, you can search on ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=childhood%20acute%20myeloid%20leukemia.
Actionable guidance for navigating care for childhood acute myeloid leukemia
To navigate childhood acute myeloid leukemia, consider seeking a pediatric hematologist-oncologist with expertise in treating AML. They can provide specialized care tailored to your child's needs. Additionally, engaging with clinical trials may offer access to cutting-edge therapies. For resources, visit GARD at rarediseases.info.nih.gov for information on rare diseases and potential support networks. Participation in clinical trials can also provide valuable insights into the disease's progression and treatment.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 30, 2026
Consider asking your healthcare providers these condition-specific questions
Genetic and Rare Diseases Info Center
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 3 companies have orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.